Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-23-127621
Filing Date
2023-04-28
Accepted
2023-04-28 17:14:35
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d468878d10ka.htm   iXBRL 10-K/A 580493
2 EX-31.1 d468878dex311.htm EX-31.1 3561
3 EX-31.2 d468878dex312.htm EX-31.2 3887
  Complete submission text file 0001193125-23-127621.txt   876856

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA wve-20221231.xsd EX-101.SCH 4944
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20221231_cal.xml EX-101.CAL 656
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20221231_def.xml EX-101.DEF 17679
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20221231_lab.xml EX-101.LAB 23281
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20221231_pre.xml EX-101.PRE 19258
10 EXTRACTED XBRL INSTANCE DOCUMENT d468878d10ka_htm.xml XML 8353
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37627 | Film No.: 23868276
SIC: 2834 Pharmaceutical Preparations